Ondansetron: A Selective 5‐HT3Receptor Antagonist and Its Applications in CNS‐Related Disorders
Authors:
- 7 June 2001
- journal article
- review article
- Published by Wiley in CNS Drug Reviews
- Vol. 7 (2) , 199-213
Abstract
Ondansetron is a selective 5‐hydroxytryptamine3 (5‐HT3) receptor antagonist that has been introduced to clinical practice as an antiemetic for cancer treatment‐induced and anesthesia‐related nausea and vomiting. Its use under these circumstances is both prophylactic and therapeutic. It has a superior efficacy, safety and pharmacoeconomic profile compared with other groups of antiemetics, namely antidopaminergics, antihistamines and anticholinergics. However, its place in the management of anticipatory and delayed vomiting in cancer treatment and as a rescue antiemetic in surgical patients needs to be further explored. Furthermore, recent animal and human research also reflects its possible novel application in the treatment of other disease states, such as alcoholism, cocaine addiction, opioid withdrawal syndrome, anxiety disorders, gastrointestinal motility disorders, Tourette's syndrome and pruritus. This review revisits the widespread physiological and pathological effects of 5‐HT and discusses both the basic science literature and the clinical developments responsible for the conventional and novel uses of ondansetron. In addition, new discoveries relating to the effects of ondansetron on other receptors/channels and their possible therapeutic applications are presented.Keywords
This publication has 65 references indexed in Scilit:
- Intravenous ondansetron for the control of opioid-induced nausea and vomitingClinical Therapeutics, 1999
- 5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in RatsNeurobiology of Learning and Memory, 1999
- Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetronEuropean Journal of Gastroenterology & Hepatology, 1998
- 5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and VomitingDrugs, 1998
- Effects of ondansetron pretreatment on acute responses to ethanol in social drinkersBehavioural Pharmacology, 1994
- Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flowPsychiatry Research: Neuroimaging, 1991
- The concept of selectivity in 5-HT receptor researchEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamineNeuropharmacology, 1986